Exicure Inc
XCUR4.390USD
+0.360+8.93%
收盘 02/09, 16:00（美东）报价延迟15分钟
1.04M总市值
亏损市盈率 TTM
关于 Exicure Inc 公司
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Exicure Inc简介
公司代码XCUR
公司名称Exicure Inc
上市日期May 09, 2018
CEOYoo (Andy)
员工数量7
证券类型Ordinary Share
年结日May 09
公司地址2430 N. Halsted St.
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编60614
电话18476731707
网址https://www.exicuretx.com/
公司代码XCUR
上市日期May 09, 2018
CEOYoo (Andy)
Exicure Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 1月27日 周二
更新时间: 1月27日 周二
持股股东
股东类型
持股股东
持股股东
占比
Exicure Hitron Inc. Employees
25.09%
DGP Co., Ltd.
7.73%
Abingworth Management Limited
4.42%
CBI USA, Inc.
2.57%
The Vanguard Group, Inc.
0.66%
其他
59.54%
持股股东
持股股东
占比
Exicure Hitron Inc. Employees
25.09%
DGP Co., Ltd.
7.73%
Abingworth Management Limited
4.42%
CBI USA, Inc.
2.57%
The Vanguard Group, Inc.
0.66%
其他
59.54%
股东类型
持股股东
占比
Corporation
35.38%
Venture Capital
4.42%
Investment Advisor
0.77%
Investment Advisor/Hedge Fund
0.46%
Hedge Fund
0.03%
Research Firm
0.03%
其他
58.90%
机构持股
更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
20
392.11K
12.77%
--
2025Q4
31
364.43K
5.72%
-496.82K
2025Q3
34
828.16K
12.99%
+419.96K
2025Q2
39
5.19M
82.14%
+459.49K
2025Q1
39
5.11M
80.94%
+626.75K
2024Q4
39
2.19M
79.53%
+1.26M
2024Q3
38
1.16M
47.48%
+231.16K
2024Q2
41
935.92K
56.32%
-7.21K
2024Q1
63
954.65K
57.41%
-102.69K
2023Q4
69
1.01M
60.85%
-61.54K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Exicure Hitron Inc. Employees
3.33M
52.3%
--
--
Sep 18, 2025
DGP Co., Ltd.
492.61K
7.73%
--
--
Sep 09, 2025
Abingworth Management Limited
281.64K
4.42%
--
--
Sep 30, 2025
CBI USA, Inc.
163.66K
2.57%
--
--
Sep 12, 2024
The Vanguard Group, Inc.
42.04K
0.66%
+14.21K
+51.03%
Sep 30, 2025
Geode Capital Management, L.L.C.
29.32K
0.46%
+10.36K
+54.63%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.45K
0.09%
+2.79K
+105.20%
Sep 30, 2025
Tower Research Capital LLC
2.03K
0.03%
+1.06K
+108.41%
Sep 30, 2025
Morgan Stanley & Co. LLC
1.90K
0.03%
+1.44K
+317.84%
Sep 30, 2025
UBS Financial Services, Inc.
18.70K
0.29%
-7.57K
-28.80%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
公告日期
除权除息日
类型
比率
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
